Treatment algorithms

Table 1: Algorithm for treatment with TNF inhibitors of patients with treatment failure.

Measurable drug level
/ Negative for NAbs

Drug level below detection limit / Negative for NAbs

Drug level below detection limit / Positive for NAbs

• Compliance issues? Does the patient take the medication as directed?
• Does the patient need a higher drug dose or more frequent dosing interval?
• The patient’s disease is not driven by TNF levels. Change type of treatment.
• Was the sample collected at Cmin? NAbs are measured with optimal result at Cmin.

• Compliance issues? Does the patient take the medication as directed?
• Does the patient need a higher drug dose or more frequent dosing interval?
• Non-neutralizing ADA can both limit the bioavailability (with local administration of the drug) and increase the elimination of drug in circulation.

• Change TNF inhibitor because NAbs influence the activity of the currently used TNF inhibitor.

Inspiration from Bendtzen 2011, 2013, Garcês 2013, Vincent 2013.

 

Table 2: Algorithm for treatment with TNF inhibitors of patients that respond to treatment.

Measurable drug level /Negative for NAbs

Drug level below the detection limit / Positive for NAbs

• Everything is OK. Follow up with new tests at regular intervals.
• Should the drug dosage be adjusted?
• Is the patient is in remission and can treatment be discontinue?

• The patient is in remission and can formally discontinue treatment.

Inspiration from Bendtzen 2011, 2013, Garcês 2013, Vincent 2013.

20 years experience

Product News

April 19, 2019
Opening hours – Spring 2019 »

The laboratory’s opening hours will change during the Easter holidays and other holidays during the Spring of 2019.

April 18, 2019
Updates in our range of tests »

We no longer offer analysis of biomarker 14-3-3 in CSF (Creutzfeldt-Jakob test). Stop date; 23 April 2019.